At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Study to Assess the Safety, Tolerability, and Immunogenicity of Licensed Seasonal Trivalent Influenza Vaccine Administered by Needle-free Jet Injection in One Intramuscular Dose to Healthy Young Adults
In Brief
A Phase 4 clinical trial evaluating LectraJet, TIV by jet injection, and 1 other intervention for Healthy Adults. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This research study involves testing of a device that can give injections (shots) without the use of a needle.
Study Details
Timeline
Interventions
LectraJet is a new jet injector studied for the first time in humans. It is in the category known as disposable-syringe jet injectors that have the advantage of eliminating the risk of disease transmission between subjects. A new syringe and nozzle is used for each patient so that no splash back of blood can occur onto the jet apparatus itself.
Administration of seasonal trivalent influenza vaccine (TIV) by jet injection
Licensed trivalent influenza vaccine provided by either jet injection or traditional needle and syringe.